Inhibition of ACAT as a Therapeutic Target for Alzheimer’s Disease Is Independent of ApoE4 Lipidation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Inhibition of ACAT as a Therapeutic Target for Alzheimer’s Disease Is Independent of ApoE4 Lipidation ; volume:20 ; number:4 ; day:8 ; month:5 ; year:2023 ; pages:1120-1137 ; date:7.2023
Neurotherapeutics ; 20, Heft 4 (8.5.2023), 1120-1137, 7.2023
- Urheber
-
Valencia-Olvera, Ana C.
Balu, Deebika
Faulk, Naomi
Amiridis, Aspasia
Wang, Yueting
Pham, Christine
Avila-Munoz, Eva
York, Jason M.
Thatcher, Gregory R. J.
LaDu, Mary Jo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13311-023-01375-3
- URN
-
urn:nbn:de:101:1-2023110610432687060831
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Valencia-Olvera, Ana C.
- Balu, Deebika
- Faulk, Naomi
- Amiridis, Aspasia
- Wang, Yueting
- Pham, Christine
- Avila-Munoz, Eva
- York, Jason M.
- Thatcher, Gregory R. J.
- LaDu, Mary Jo
- SpringerLink (Online service)
Ähnliche Objekte (12)
ApoE4: an emerging therapeutic target for Alzheimer’s disease
Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
Author Correction: Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules
Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer’s disease
A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer’s disease mouse model
Lag-time in Alzheimer’s disease patients: a potential plasmatic oxidative stress marker associated with ApoE4 isoform
Apolipoprotein E4 as a Novel Treatment Target for Alzheimer’s Disease
Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer’s Disease drug candidate
FSH and ApoE4 contribute to Alzheimer’s disease-like pathogenesis via C/EBPβ/δ-secretase in female mice
ApoE4: an emerging therapeutic target for Alzheimer’s disease
Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
Author Correction: Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules
Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer’s disease
A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer’s disease mouse model
Lag-time in Alzheimer’s disease patients: a potential plasmatic oxidative stress marker associated with ApoE4 isoform
Apolipoprotein E4 as a Novel Treatment Target for Alzheimer’s Disease
Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer’s Disease drug candidate
FSH and ApoE4 contribute to Alzheimer’s disease-like pathogenesis via C/EBPβ/δ-secretase in female mice
ApoE4: an emerging therapeutic target for Alzheimer’s disease
Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
Author Correction: Serum proteomics reveal APOE-ε4-dependent and APOE-ε4-independent protein signatures in Alzheimer’s disease
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules
Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer’s disease
A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer’s disease mouse model
Lag-time in Alzheimer’s disease patients: a potential plasmatic oxidative stress marker associated with ApoE4 isoform
Apolipoprotein E4 as a Novel Treatment Target for Alzheimer’s Disease
Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer’s Disease drug candidate